{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:09:39Z","timestamp":1778728179502,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["BPS-2022C3-30021"],"award-info":[{"award-number":["BPS-2022C3-30021"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL153584"],"award-info":[{"award-number":["K23HL153584"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Randomized trials evaluating emergency treatments may be conducted with Exception from Informed Consent (EFIC) when informed consent is infeasible. In EFIC trials, a period of community consultation and public disclosure precedes initiation of enrollment. The Randomized Trial of Sedative Choice for Intubation (RSI) was a 2,365-patient randomized trial conducted with EFIC in 14 emergency departments and intensive care units across the United States. This manuscript reports the approach to community consultation and public disclosure in the RSI trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Community consultation and public disclosure were conducted locally in each region of enrolling sites. The coordinating center provided sites with templates and access to an engagement coordinator to assist with developing and executing site plans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Community consultation and public disclosure occurred at the coordinating center from February 2021-January 2022 and in the regions of the five additional enrolling sites from September 2023-June 2024. Community consultation included in-person surveys with 789 patients or family members in emergency department or intensive care unit waiting rooms and invitation of more than 200 local groups to town halls or Community Engagement Studios. Public disclosure included (i) social media advertisements viewed more than 1.2 million times, (ii) a trial website with more than 16,000 unique visitors, (iii) informational flyers in hospitals and public settings, and (iv) featured information in traditional media. Completing local community consultation and public disclosure required an average of 139\u00a0h of research personnel time and approximately $18,822 at each site, in addition to coordinating center effort and costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pre-trial community consultation activities in the RSI trial engaged over 1,000 patients, families, and community members and public disclosure reached over 1.2 million community members. While the total cost and duration of activities at sites were substantially lower than reported in prior EFIC trials, these costs remained significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov; No.: NCT05277896; URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\" ext-link-type=\"uri\">www.clinicaltrials.gov<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09665-9","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:17:53Z","timestamp":1775783873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Community consultation and public disclosure for the Randomized Trial of Sedative Choice for Intubation"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9555-6337","authenticated-orcid":false,"given":"Ariel A.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany L.","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian E.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adit A.","family":"Ginde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy A.","family":"Trent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek W.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Prekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Palakshappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jane","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan L.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley D.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie C.","family":"DeMasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cori","family":"Withers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolynn","family":"Lyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah R.","family":"Whitson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd W.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley H.","family":"Self","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew W.","family":"Semler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the RSI investigators and the Pragmatic Critical Care Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Maycee","family":"Cain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Frawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"9665_CR1","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration. Protection of human subjects; informed consent and waiver of informed consent requirements in certain emergency research; final rules. Fed Regist. 1996;61(192):51497\u2013531. Codified at 21 CFR \u00a750.24."},{"issue":"5","key":"9665_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/journalofethics.2018.20.5.stas1-1805","volume":"20","author":"SA Tisherman","year":"2018","unstructured":"Tisherman SA. Defining \u201ccommunity\u201d and \u201cconsultation\u201d for emergency research that requires an exception from informed consent. AMA J Ethics. 2018;20(5):467\u201374.","journal-title":"AMA J Ethics"},{"issue":"6","key":"9665_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/acem.13173","volume":"24","author":"GF O\u2019Malley","year":"2017","unstructured":"O\u2019Malley GF, Giraldo P, Deitch K, Aguilera EA, Cadar S, Lares C, et al. A novel emergency department-based community notification method for clinical research without consent. Acad Emerg Med Off J Soc Acad Emerg Med. 2017;24(6):721\u201331.","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"issue":"10","key":"9665_CR4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1377\/hlthaff.2018.0501","volume":"37","author":"WB Feldman","year":"2018","unstructured":"Feldman WB, Hey SP, Kesselheim AS. A systematic review of the food and drug administration\u2019s \u2018exception from informed consent\u2019 pathway. Health Aff (Millwood). 2018;37(10):1605\u201314.","journal-title":"Health Aff (Millwood)"},{"key":"9665_CR5","doi-asserted-by":"crossref","unstructured":"DeMasi SC, Imhoff B, Lewis AA, Seitz KP, Driver BE, Gibbs KW, et al. Protocol and statistical analysis plan for a multicenter randomized trial of ketamine vs etomidate for emergency tracheal intubation. CHEST Crit Care. 2025;3(3). Available from: https:\/\/www.chestcc.org\/article\/S2949-7884(25)00050-4\/fulltext","DOI":"10.1016\/j.chstcc.2025.100177"},{"key":"9665_CR6","doi-asserted-by":"publisher","unstructured":"Casey JD, Seitz KP, Driver BE, Gibbs KW, Ginde AA, Trent SA, et al. Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults. N Engl J Med. 2025.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2511420. Epub ahead of print. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2511420. Cited 2025 Dec 31.","DOI":"10.1056\/NEJMoa2511420"},{"issue":"16","key":"9665_CR7","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.107.186661","volume":"116","author":"H Halperin","year":"2007","unstructured":"Halperin H, Paradis N, Mosesso V, Nichol G, Sayre M, Ornato JP, et al. Recommendations for implementation of community consultation and public disclosure under the food and drug administration\u2019s \u201cexception from informed consent requirements for emergency research.\u201d Circulation. 2007;116(16):1855\u201363.","journal-title":"Circulation"},{"key":"9665_CR8","unstructured":"About \u2013 Pragmatic Critical Care Research Group PCCRG. Available from: https:\/\/www.pragmaticcriticalcare.org\/about\/. Cited 2025 Jan 10."},{"issue":"12","key":"9665_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/ACM.0000000000000794","volume":"90","author":"YA Joosten","year":"2015","unstructured":"Joosten YA, Israel TL, Williams NA, Boone LR, Schlundt DG, Mouton CP, et al. Community engagement studios: a structured approach to obtaining meaningful input from stakeholders to inform research. Acad Med J Assoc Am Med Coll. 2015;90(12):1646\u201350.","journal-title":"Acad Med J Assoc Am Med Coll"},{"key":"9665_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.resuscitation.2018.12.006","volume":"135","author":"JN Carlson","year":"2019","unstructured":"Carlson JN, Zive D, Griffiths D, Brown KN, Schmicker RH, Herren H, et al. Variations in the application of exception from informed consent in a multicenter clinical trial. Resuscitation. 2019;135:1\u20135.","journal-title":"Resuscitation"},{"issue":"10","key":"9665_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/acem.14264","volume":"28","author":"NW Dickert","year":"2021","unstructured":"Dickert NW, Metz K, Fetters MD, Haggins AN, Harney DK, Speight CD, et al. Meeting unique requirements: Community consultation and public disclosure for research in emergency setting using exception from informed consent. Acad Emerg Med. 2021;28(10):1183\u201394.","journal-title":"Acad Emerg Med"},{"issue":"2","key":"9665_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/acem.14377","volume":"29","author":"CH Hsu","year":"2022","unstructured":"Hsu CH, Fowler J, Cranford JA, Thomas MP, Neumar RW. Integration of social media with targeted emails and in-person outreach for exception from informed consent community consultation. Acad Emerg Med Off J Soc Acad Emerg Med. 2022;29(2):217\u201327.","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"issue":"9","key":"9665_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamasurg.2024.2147","volume":"159","author":"SW Stephens","year":"2024","unstructured":"Stephens SW, Carroll-Ledbetter C, Duckert S, Coffman T, Nelson M, Brown KN, et al. Interactive media-based approach for an exception from informed consent trial involving patients with trauma. JAMA Surg. 2024;159(9):1051\u20138.","journal-title":"JAMA Surg"},{"issue":"7","key":"9665_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/acem.14884","volume":"31","author":"CE Ward","year":"2024","unstructured":"Ward CE, Adelgais KM, Holsti M, Jacobsen KK, Simon HK, Morris CR, et al. Public support for and concerns regarding pediatric dose optimization for seizures in emergency medical services: an exception from informed consent (EFIC) trial. Acad Emerg Med. 2024;31(7):656\u201366.","journal-title":"Acad Emerg Med"},{"key":"9665_CR15","unstructured":"Regulations.gov. 2024. Public Disclosure from Vanderbilt University Medical Center. Available from: https:\/\/www.regulations.gov\/document\/FDA-1995-S-0036-0230. Cited 2025 Jan 10."},{"issue":"10 Suppl 1","key":"9665_CR16","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/MLR.0000000000000778","volume":"56 Suppl 10 Sup","author":"AP Boyer","year":"2018","unstructured":"Boyer AP, Fair AM, Joosten YA, Dolor RJ, Williams NA, Sherden L, et al. A multilevel approach to stakeholder engagement in the formulation of a clinical data research network. Med Care. 2018;56 Suppl 10 Suppl 1(10 Suppl 1):S22-6.","journal-title":"Med Care"},{"issue":"12","key":"9665_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2217\/cer-2018-0046","volume":"7","author":"CH Wilkins","year":"2018","unstructured":"Wilkins CH, Villalta-Gil V, Houston MM, Joosten Y, Richmond A, Vaughn YC, et al. Development and validation of the person-centeredness of research scale. J Comp Eff Res. 2018;7(12):1153\u20139.","journal-title":"J Comp Eff Res"},{"issue":"1","key":"9665_CR18","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1017\/cts.2024.659","volume":"8","author":"M Tischbein","year":"2024","unstructured":"Tischbein M, Cook SK, Shyr C, Benhoff K, Baig A, Quarles K, et al. Expert advice from ResearchMatch volunteers: recruitment innovation center use cases and innovation. J Clin Transl Sci. 2024;8(1):e223.","journal-title":"J Clin Transl Sci"},{"issue":"6","key":"9665_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/17407745241243045","volume":"21","author":"T Gugel","year":"2024","unstructured":"Gugel T, Adams K, Baranoski M, Yanez ND, Kampp M, Johnson T, et al. Design and implementation of community consultation for research conducted under exception from informed consent regulations for the PreVent and the PreVent 2 trials: changes over time and during the COVID-19 pandemic. Clin Trials. 2024;21(6):671\u201380.","journal-title":"Clin Trials"},{"issue":"1","key":"9665_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/23294515.2020.1818878","volume":"12","author":"M Chisolm-Straker","year":"2021","unstructured":"Chisolm-Straker M, Nassisi D, Daya MR, Cook JNB, Wilets IF, Clesca C, et al. Exception from informed consent: How IRB reviewers assess community consultation and public disclosure. AJOB Empir Bioeth. 2021;12(1):24\u201332.","journal-title":"AJOB Empir Bioeth"},{"key":"9665_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.resuscitation.2018.06.031","volume":"130","author":"L Eubank","year":"2018","unstructured":"Eubank L, Lee KS, Seder DB, Strout T, Darrow M, MacDonald C, et al. Approaches to community consultation in exception from informed consent: analysis of scope, efficiency, and cost at two centers. Resuscitation. 2018;130:81\u20137.","journal-title":"Resuscitation"},{"key":"9665_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.resuscitation.2018.04.033","volume":"128","author":"G Matchett","year":"2018","unstructured":"Matchett G, Ryan TJ, Sunna MC, Lee SC, Pepe PE. Measuring the cost and effect of current community consultation and public disclosure techniques in emergency care research. Resuscitation. 2018;128:37\u201342.","journal-title":"Resuscitation"},{"issue":"4","key":"9665_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1553-2712.2012.01328.x","volume":"19","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Biros MH, Harney D, Dickert N, Baren J. Implementation of the exception from informed consent regulations in a large multicenter emergency clinical trials network; the RAMPART experience. Acad Emerg Med. 2012;19(4):448\u201354.","journal-title":"Acad Emerg Med"},{"issue":"3","key":"9665_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/TA.0000000000004465","volume":"98","author":"SW Stephens","year":"2025","unstructured":"Stephens SW, Carroll-Ledbetter CR, Duckert S, Coffman TW, Nelson MA, Rodgers J, et al. Analysis of time to regulatory approval in an exception from informed consent trial in trauma patients. J Trauma Acute Care Surg. 2025;98(3):492.","journal-title":"J Trauma Acute Care Surg"},{"key":"9665_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jss.2018.09.007","volume":"234","author":"JA Harvin","year":"2019","unstructured":"Harvin JA, Podbielski JM, Vincent LE, Liang MK, Kao LS, Wade CE, et al. Impact of social media on community consultation in exception from informed consent clinical trials. J Surg Res. 2019;234:65\u201371.","journal-title":"J Surg Res"},{"issue":"1","key":"9665_CR26","doi-asserted-by":"publisher","first-page":"e000830","DOI":"10.1136\/tsaco-2021-000830","volume":"6","author":"P Farley","year":"2021","unstructured":"Farley P, Stephens SW, Crowley B, Collins SP, Wong MD, Panas AB, et al. Exception from informed consent trials: social-media-based community consultation campaigns are representative of target communities. Trauma Surg Acute Care Open. 2021;6(1):e000830.","journal-title":"Trauma Surg Acute Care Open"},{"issue":"4","key":"9665_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/bc.bc_44_21","volume":"7","author":"ME Inam","year":"2021","unstructured":"Inam ME, Sanzgiri A, Lekka E, Sheth SA, Barreto AD, Savitz SI, et al. Exception from informed consent in the era of social media: the SEGA stroke trial experience. Brain Circ. 2021;7(4):253\u20138.","journal-title":"Brain Circ"},{"key":"9665_CR28","unstructured":"Office of the Commissioner. Exception from Informed Consent Requirements for Emergency Research. FDA; 2013. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/exception-informed-consent-requirements-emergency-research. Cited 2025 June 26."},{"issue":"19","key":"9665_CR29","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1001\/jama.282.19.1857","volume":"282","author":"EP Sloan","year":"1999","unstructured":"Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 1999;282(19):1857\u201364.","journal-title":"JAMA"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09665-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09665-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09665-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:30:48Z","timestamp":1778725848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09665-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9665"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09665-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board (IRB) at Vanderbilt University Medical Center gave ethical approval for the RSI trial protocol (IRB number: 210500). The RSI trial protocol was also approved by the US Food and Drug Administration (FDA) (IND 141424). The study was conducted\u00a0with Exception from Informed Consent Requirements for Emergency Research (EFIC) (21 CFR 50.24). Plans for community consultation and public disclosure were approved by the single IRB at Vanderbilt University Medical Center. The IRB of each participating site provided local context for the community consultation and public disclosure plan and activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial conflicts of interest relevant to the current work.B.E.D. reported having received compensation from UpToDate unrelated to the current work.A.A.G. reported having received compensation from Biomeme, SeaStar, and National Institutes of Health, unrelated to the current work.S.A.T. reported having received compensation from the American College of Emergency Physicians unrelated to the current work.D. W. R. reported having received compensation from ABSS Solutions, Quantum Leap Healthcare Collaborative, Critical Care Clinical Trial Network, Achieve Life Sciences, and Direct Biologics unrelated to the current work.J.A.P. reported having received compensation from American College of Chest Physicians unrelated to the current work.J.P.G. reported having received compensation from American College of Chest Physicians unrelated to the current work.T.W.R. reported having received compensation from Cumberland Pharmaceuticals, Cytovale, Nestle, and Sanofi unrelated to the current work.M.W.S. reported having received compensation from Baxter Healthcare Corporation, DynaMedex, and Reprieve Cardiovascular, Inc unrelated to the current work.J.D.C. reported compensation from Reprieve Cardiovascular, Inc unrelated to the current work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"368"}}